PDF herunterladen
Aktuelle Neurologie 2007; 34(1): 23-33
DOI: 10.1055/s-2006-951919
Übersicht
© Georg Thieme Verlag KG Stuttgart · New York

Chronische Meningitis

Chronic MeningitisR.  Helbok1 , E.  Schmutzhard1
  • 1Universitätsklinik für Neurologie, Medizinische Universität Innsbruck
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
01. Februar 2007 (online)

Auch verfügbar auf
    Lizenzen und Reprints

Zusammenfassung

Die chronische Meningitis ist eine progressive Erkrankung mit subakutem Beginn für mindestens ein Monat und persistierender Liquor-cerebrospinalis-Pleozytose. Das differenzialdiagnostische Spektrum ist sehr breit und umfasst sowohl primär infektiöse (zum Beispiel Mycobacterium tuberculosis, Cryptococcus neoformans und andere opportunistische Erreger) als auch nichtinfektiöse Ursachen (zum Beispiel Meningeosis carcinomatosa, Erkrankungen aus dem kollagen-vaskulitischen Formenkreis). Die Vielzahl möglicher Differenzialdiagnosen macht es besonders notwendig, bei jedem Patienten eine genaueste Anamnese (Reiseexposition usw.) und gründliche allgemeinmedizinische Untersuchung durchzuführen. Die Vorgehensweise bei chronischer Meningitis wurde bisher noch nicht in Studien standardisiert. In diesem Review werden die häufigsten Ursachen einer chronischen Meningitis beschrieben und die wichtigsten diagnostischen Schritte speziell in Tabellen angeführt. Durch das Auftreten der HIV-Pandemie im speziellen und durch die zunehmende Anzahl an immunsupprimierten Patienten hat sich das Erregerspektrum und die Prognose deutlich verändert. Die chronische Meningitis stellt immer noch eine Herausforderung für jeden Kliniker dar. Trotz zum Teil aufwändigster und hochspezifischer diagnostischer Verfahren bleibt bei zirka einem Drittel der Patienten mit einer chronischen Meningitis die Ätiologie ungeklärt. Die Prognose ist erregerabhängig und vor allem bei der chronisch idiopathischen Meningitis günstig.

Abstract

Chronic meningitis is an inflammation of the meninges with subacute onset and persisting cerebrospinal fluid (CSF) abnormalities lasting for at least one month. Several non-infectious (meningeosis carcinomatosa, collagen vascular diseases, toxic) and infectious aetiologies (e. g., Mycobacterium tuberculosis, Cryptococcus neoformans and other opportunistic pathogens) are known to be causative. The wide range of different aetiologies renders the approach to patients with this syndrome particularly difficult. There is no standardized diagnostic procedure, thus, taking an in depth history combined with a complete physical examination is mandatory in every patient. We review the most important infectious and non-infectious causes of chronic meningitis in terms of epidemiology, diagnosis, therapy and prognosis and summarise important clues for diagnosis and CSF findings in tables. Immunodeficiency (HIV, organ transplant, medication) has a tremendous impact on the chronic meningitis syndrome and will be discussed separately. This syndrome is still a diagnostic challenge for each and every physician. Despite sophisticated laboratory analyses, the aetiology of the disease in one-third of the patients still remains unclear. However, most patients with idiopathic chronic meningitis have a relatively good outcome.

Literatur

  • 1 Ellner J J, Bennet J E. Chronic meningitis.  Medicine. 1976;  55 341-369
    PubMedGoogle Scholar
  • 2 Vinas F C, Rengachary S. Diagnosis and management of neurosarcoidosis.  J Clin Neuroscience. 2001;  8 505-513
    CrossrefPubMedGoogle Scholar
  • 3 Willhelm C S, Marra C M. Chronic meningitis.  Semin Neuro. 1992;  12 2234-2247
    PubMedGoogle Scholar
  • 4 Helbok R, Pongpakdee S, Yenjun S. et al . Chronic meningitis in Thailand. Clinical characteristics, laboratory data and outcome in patients with specific reference to tuberculosis and cryptococcosis.  Neuroepidemiology. 2006;  26 37-44
    CrossrefPubMedGoogle Scholar
  • 5 WHO Report 2006 Global Tuberculosis Control .Surveillance, planning, financing. http://www.who.int/tb/publications/global_report/en/index.html
    Google Scholar
  • 6 Medical Research . Council Report: streptomycin treatment of tuberculous meningitis.  Lancet. 1948;  1 582-596
    PubMedGoogle Scholar
  • 7 Bonington A, Strang J I, Klappe P E. et al . Use of Roche AMPLICOR Mycobacterium tuberculosis PCR in early diagnosis of tuberculous meningitis.  J Clin Microbiol. 1998;  36 1251
    PubMedGoogle Scholar
  • 8 Noordhoek G T, Kolk A H, Bjune G. et al . Sensitivity and specificity of PCR for detection of Mycobacterium tuberculosis: A blind comparison study among seven laboratories.  J Clin Microbiol. 1994;  32 277
    PubMedGoogle Scholar
  • 9 Horsburgh Jr C R, Feldman S, Ridzon R. Practice guidelines for the treatment of tuberculosis.  Clin Infect Dis. 2000;  31 633-639
    CrossrefPubMedGoogle Scholar
  • 10 Anonymous . Prevention and treatment od tuberculosis amond patients infected with human immunodeficiency virus: Principles of therapy and revised recommendations. Centers for Disease Control and Prevention.  MMWR. 1998;  47 (RR-20) 1
    PubMedGoogle Scholar
  • 11 Kent S J, Crowe S M, Yung A. et al . Tuberculous meningitis: a 30-year review.  Clin Infect Dis. 1993;  17 987-994
    CrossrefPubMedGoogle Scholar
  • 12 Dube M P, Holtom P D, Larsen R A. Tuberculous meningitis in patients with and without human immunodeficiency virus infection.  Am J Med. 1992;  93 520-524
    CrossrefPubMedGoogle Scholar
  • 13 Cox G M, Perfect J R. AIDS-associated cryptococcal meningoencephalitis.  www.uptodate.com 2006
    Google Scholar
  • 14 Cox G M, Perfect J R. Cryptococcus neoformans var neoformans and gattii and Trichosporon species. In: Edward LA (ed) Topley and Wilson's Microbiology and Microbial Infections (9th Ed). London; Arnold Press 1997
    Google Scholar
  • 15 Graybill J R, Sobel J, Saag M. et al . Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis.  Clin Infect Dis. 2000;  30 47-54
    CrossrefPubMedGoogle Scholar
  • 16 Tanner D C, Weinstein M P, Fedorciw B. et al . Comparison of commercial kits for detection of cryptococcal antigen.  J Clin Microbiol. 1994;  32 1680-1684
    CrossrefPubMedGoogle Scholar
  • 17 Powderly W G, Cloud G A, Dismukes W E, Saag M S. Measurement of cryptococcal antigen in serum and cerebrospinal fluid: Value in the management of AIDS-associated cryptococcal meningitis.  Clin Infect Dis. 1994;  18 789-792
    PubMedGoogle Scholar
  • 18 Bennett J E, Dismukes W E, Duma R J. et al . A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptococcal meningitis.  N Engl J Med. 1979;  301 126-131
    CrossrefPubMedGoogle Scholar
  • 19 Saag M S, Powderly W G, Cloud G A. et al . Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis.  N Engl J Med. 1992;  326 83-89
    PubMedGoogle Scholar
  • 20 Horst C M Van der, Saag M S, Cloud G A. et al . Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome.  N Engl J Med. 1997;  337 15-21
    CrossrefPubMedGoogle Scholar
  • 21 Dismukes W E, Cloud G, Gallis H A. et al . Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks.  N Engl J Med. 1987;  317 334-341
    CrossrefPubMedGoogle Scholar
  • 22 Schmutzhard E, Vejajjiva A. Treatment of cryptococcal meningitis with high-dose, long-term combination amphotericin B and flucytosine.  Am J Med. 1988;  85 737-738
    PubMedGoogle Scholar
  • 23 Brouwer A E, Rajanuwong A, Chierakul W. et al . Combination antifungal therapies for HIV-associated cryptococcal meningitis: A randomised trial.  Lancet. 2004;  363 1764-1767
    CrossrefPubMedGoogle Scholar
  • 24 Mussini C, Pezzotti P, Miro J M. et al . Discontinuation of maintenance therapy for cryptococcal meningitis in patients with AIDS treated with highly active antiretroviral therapy: an international observational study.  Clin Infect Dis. 2004;  38 565-571
    CrossrefPubMedGoogle Scholar
  • 25 Diamond R D, Bennett J E. Prognostic factors in cryptococcal meningitis. A study of 111 cases.  Ann Intern Med. 1974;  80 176-181
    PubMedGoogle Scholar
  • 26 Johnson R H, Einstein H E. Coccidioidal meningitis.  Clin Infect Dis. 2006;  42 103-107
    CrossrefPubMedGoogle Scholar
  • 27 Wheat L J, Kauffman C A. Histoplasmosis.  Infect Dis Clin N Am. 2003;  17 1-19
    CrossrefPubMedGoogle Scholar
  • 28 Dewsnup D H, Galgiani J N, Graybill J R. et al . Is it ever safe to stop azole therapy for Coccidioides immitis meningitis?.  Ann Intern Med. 1996;  124 305-310
    CrossrefPubMedGoogle Scholar
  • 29 Wheat L J, Batteiger B E, Sathapatayavongs B. Histoplasma capsulatum infections of the central nervous system: a clinical review.  Medicine (Baltimore). 1990;  69 244-260
    CrossrefPubMedGoogle Scholar
  • 30 Wheat L. Histoplasmosis in the acquired immunodeficiency syndrome.  Curr Top Med Mycol. 1996;  7 7-18
    PubMedGoogle Scholar
  • 31 Chapman S W, Lin A C, Hendricks A. Endemic blastomycosis in Mississippio: Epidemiological and clinical studies.  Semin Respir Infect. 1997;  12 219-228
    PubMedGoogle Scholar
  • 32 Meyding-Lamadé U. Chronische lymphozytäre Meningitis. In: Wildemann B, Fogel W, Grau A (Hrsg) Therapieleitfaden Neurologie. Stuttgart; W. Kohlhammer 2003: 196-197
    Google Scholar
  • 33 Barton L L. et al . Congenital lymphocytic choriomeningitis virus infection: decade of rediscovery.  Clin Infect Dis. 2001;  33 370-374
    CrossrefPubMedGoogle Scholar
  • 34 Carpio A. Neurocysticercosis: an update.  Lancet Infect Dis. 2002;  2 751-762
    CrossrefPubMedGoogle Scholar
  • 35 Hommann M, Schotte U, Voigt R. et al . Cerebral toxoplasmosis after combined liverpancreas-kidney and liver-pancreas transplantation.  Transplant Proc. 2002;  34 2294-2295
    CrossrefPubMedGoogle Scholar
  • 36 Mele A, Paterson P J, Prentice H G. et al . Toxoplasmosis in bone marrow transplantation: a report of two cases and systematic review of the literature.  Bone Marrow Transplant. 2002;  29 691-698
    CrossrefPubMedGoogle Scholar
  • 37 Slom T J, Cortese M M, Gerber S I. et al . An outbreak of eosinophilic meningitis caused by Angiostrongylus cantonensis in travelers returning from the Caribbean.  N Engl J Med. 2002;  346 668-675
    CrossrefPubMedGoogle Scholar
  • 38 Tsai H C, Liu Y C, Kuni C. et al . Eosinophilic meningitis caused by angiostrongylus cantonensis: report of 17 cases.  Am J Med. 2001;  111 109-114
    CrossrefPubMedGoogle Scholar
  • 39 Eamsobhana P, Ongrotchanakun J, Yoolek A. et al . Multi-immunodot for rapid differential diagnosis of eosinophilic meningitis due to parasitic infections.  J Helminthol. 2006;  80 249-254
    PubMedGoogle Scholar
  • 40 Kaplan J G, DeSouza T G, Farkash A. et al . Leptomeningeal metastases: comparison of clinical features and laboratory data of solid tumors, lymphomas and leukemias.  J Neurooncol. 1990;  9 225-229
    CrossrefPubMedGoogle Scholar
  • 41 Kesari S, Batchelor T T. Leptomeningeal metastases.  Neurol Clin. 2003;  21 25-66
    CrossrefPubMedGoogle Scholar
  • 42 Posner J B. Neurologic Complications of Cancer. Philadelphia; F. A. Davis 1995
    Google Scholar
  • 43 Chamberlain M C. Carcinomatous meningitis.  Arch Neurol. 1997;  54 16-17
    PubMedGoogle Scholar
  • 44 Chamberlain M C. Neoplastic meningitis.  J Clin Oncol. 2005;  23 3605-3613
    CrossrefPubMedGoogle Scholar
  • 45 Demopoulos A. Leptomeningeal metastases.  Curr Neurol Neurosci Rep. 2004;  4 196-204
    CrossrefPubMedGoogle Scholar
  • 46 Giglio P, Weinberg J S, Forman A D. et al . Neoplastic meningitis in patients with adenocarcinoma of the gastrointestinal tract.  Cancer. 2005;  103 2355-2362
    CrossrefPubMedGoogle Scholar
  • 47 Glantz M J, Cole B F, Glantz L K. et al . Cerebrospinal fluid cytology in patients with cancer: minimizing false-negative results.  Cancer. 1998;  82 733-739
    CrossrefPubMedGoogle Scholar
  • 48 Chowdhary S, Chamberlain M. Leptomeningeal metastases: current concepts and management guidelines.  J Natl Compr Canc Netw. 2005;  3 693-703
    PubMedGoogle Scholar
  • 49 Demopoulos A, Posner J B. Treatment of leptomeningeal metastses (carcinomatous meningitis). http://www.uptodate.com 2006
    Google Scholar
  • 50 Glantz M J, Jaeckle K A, Chamberlain M C. et al . A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors.  Clin Cancer Res. 1999;  5 3394-3402
    PubMedGoogle Scholar
  • 51 Glantz M J, LaFollette S, Jaeckle K A. et al . Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis.  J Clin Oncol. 1999;  17 3110-3116
    PubMedGoogle Scholar
  • 52 Grossman D A, Finkelstein D M, Ruckdeschel J C. et al . Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. Eastern Cooperative Oncology Group.  J Clin Oncol. 1993;  11 561-569
    PubMedGoogle Scholar
  • 53 Hitchins R N, Bell D R, Woods R L, Levi J A. A prospective randomized trial of single-agent versus combination chemotherapy in meningeal carcinomatosis.  J Clin Oncol. 1987;  5 1655-1662
    PubMedGoogle Scholar
  • 54 Boogerd W, Bent M J van den, Koehler P J. et al . The relevance of intraventricular chemotherapy for leptomeningeal metastasis in breast cancer: a randomised study.  Eur J Cancer. 2004;  40 2726-2733
    CrossrefPubMedGoogle Scholar
  • 55 Smith J E, Aksamit Jr A J. Outcome of chronic idiopathic meningitis.  Mayo Clin Proc. 1994;  69 548-556
    PubMedGoogle Scholar
  • 56 Leib S L, Täuber M G. Acute and chronic meningitis. In: Cohen J, Powderly W (eds) Infectious Diseases. 2nd ed. Edinburg; Mosby 2004: 251-266
    Google Scholar
  • 57 Bvt-Akman-Demir G, Serdaroglu P, Tasci B. Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients.  Brain. 1999;  122 2171-2181
    CrossrefPubMedGoogle Scholar
  • 58 Sexton D J. Approach to the patient with chronic meningitis. http://www.uptodate.com/physicians/infectious_disease_primary.asp
    Google Scholar
  • 59 Kansu T, Kadayifcilar S. Visual Aspects of Behçet's Disease.  Current Neurology and Neuroscience Reports. 2005;  5 382-388
    PubMedGoogle Scholar
  • 60 Anderson N E, Willoughby E W, Synek B J. Leptomeningeal and brain biopsy in chronic meningitis.  Aust N Z J Med. 1995;  25 703-706
    PubMedGoogle Scholar
  • 61 Cheng T M, O'Neill B P, Scheithauer B W, Piepgras D G. Chronic meningitis: the role of meningeal or cortical biopsy.  Neurosurgery. 1994;  34 590-595
    CrossrefPubMedGoogle Scholar
  • 62 Roos K L, Hartung H P. Inflammatory and Infectious Diseases in: Neurological Therapeutics. Principles and Practice. Volume 1. London, New York; Dunitz 2003
    Google Scholar
  • 63 Schmutzhard E. Entzündliche Erkrankungen des Nervensystems. Stuttgart, New York; Thieme 2000
    Google Scholar

Dr. Raimund Helbok

Universitätsklinik für Neurologie, Medizinische Universität Innsbruck

Anichstraße 35

6020 Innsbruck, Österreich

eMail: Raimund.Helbok@uklibk.ac.at